SK298A3 - New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds - Google Patents
New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds Download PDFInfo
- Publication number
- SK298A3 SK298A3 SK2-98A SK298A SK298A3 SK 298 A3 SK298 A3 SK 298A3 SK 298 A SK298 A SK 298A SK 298 A3 SK298 A3 SK 298A3
- Authority
- SK
- Slovakia
- Prior art keywords
- oxo
- tetrahydro
- bipyridinyl
- oxazolidin
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19524765A DE19524765A1 (de) | 1995-07-07 | 1995-07-07 | Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| PCT/EP1996/002939 WO1997003072A1 (de) | 1995-07-07 | 1996-07-04 | Neue oxazolidinonderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK298A3 true SK298A3 (en) | 1998-05-06 |
Family
ID=7766252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK2-98A SK298A3 (en) | 1995-07-07 | 1996-07-04 | New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5972947A (de) |
| EP (1) | EP0839147A1 (de) |
| JP (1) | JPH11508904A (de) |
| KR (1) | KR19990028792A (de) |
| CN (1) | CN1195348A (de) |
| AU (1) | AU709208B2 (de) |
| BR (1) | BR9609327A (de) |
| CA (1) | CA2225411A1 (de) |
| CZ (1) | CZ288619B6 (de) |
| DE (1) | DE19524765A1 (de) |
| HU (1) | HUP9900348A3 (de) |
| IL (1) | IL122815A0 (de) |
| NO (1) | NO310194B1 (de) |
| NZ (1) | NZ313599A (de) |
| PL (1) | PL324436A1 (de) |
| SK (1) | SK298A3 (de) |
| TW (1) | TW332206B (de) |
| WO (1) | WO1997003072A1 (de) |
| ZA (1) | ZA965712B (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9901741A3 (en) * | 1996-03-30 | 2000-03-28 | Roche Diagnostics Gmbh | Novel oxazolidine derivatives, process for their production and medicaments containing them |
| AR012443A1 (es) * | 1997-04-16 | 2000-10-18 | Uriach & Cia Sa J | Nuevas carboxamidas como inhibidores de la agregacion plaquetaria, procedimiento para su preparacion, composiciones farmaceuticas que loscontienen y uso de los mismos en la manufactura de medicamentos |
| AR013693A1 (es) * | 1997-10-23 | 2001-01-10 | Uriach & Cia Sa J | Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria |
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
| AU2003235895A1 (en) * | 2002-05-09 | 2003-11-11 | Mochida Pharmaceutical Co., Ltd. | Process for producing 1-(4-pyridyl)-4-piperidone |
| DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| EP1805165B1 (de) * | 2004-10-18 | 2009-12-16 | Eli Lilly And Company | 1-(hetero)aryl-3-aminopyrrolidinderivate zur verwendung als antagonisten des mglur3-rezeptors |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| EP1685841A1 (de) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prophylaxe und Behandlung von thrombolischen Erkrankungen |
| DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
| DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
| EP1934208B1 (de) | 2005-10-04 | 2011-03-23 | Bayer Schering Pharma Aktiengesellschaft | Neue polymorphe form von 5-chlor-n-({ ( 5s )-2-0x0-3-[4-( 3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamid |
| DE102005048824A1 (de) * | 2005-10-10 | 2007-04-12 | Bayer Healthcare Ag | Behandlung und Prophylaxe von Mikroangiopathien |
| DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
| DE102007018662A1 (de) | 2007-04-20 | 2008-10-23 | Bayer Healthcare Ag | Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie |
| DE102007028318A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Oxazolidinone zur Behandlung und Prophylaxe von Sepsis |
| EP2138178A1 (de) | 2008-06-28 | 2009-12-30 | Bayer Schering Pharma Aktiengesellschaft | Oxazolidninone zur Behandlung der chronisch obstruktiven Lungenerkrankung (COPD) und/oder Asthma |
| EP2140866A1 (de) | 2008-07-04 | 2010-01-06 | Bayer Schering Pharma Aktiengesellschaft | Oxazolidinone zur Behandlung von Entzündungserkrankungen des Magen-Darm-Trakts |
| WO2014085413A1 (en) * | 2012-11-28 | 2014-06-05 | Temple University - Of The Commonwealth System Of Higher Education | Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators |
| CN105829304B (zh) * | 2013-12-20 | 2019-09-20 | 中国人民解放军军事医学科学院毒物药物研究所 | N,n’取代哌啶胺类化合物、其制备方法及用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9122016D0 (en) * | 1991-10-16 | 1991-11-27 | Glaxo Group Ltd | Chemical compounds |
| WO1993014077A1 (en) * | 1992-01-21 | 1993-07-22 | Glaxo Group Limited | Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| PT825184E (pt) * | 1993-03-29 | 2001-11-30 | Astrazeneca Ab | Derivados heterociclicos como inibidores de agregacao de plaquetas |
| DK0623615T3 (da) * | 1993-05-01 | 1999-12-13 | Merck Patent Gmbh | Adhæsionsreceptor-antagonister |
| DE4324393A1 (de) * | 1993-07-21 | 1995-01-26 | Merck Patent Gmbh | 4-Aryloxy- und 4-Arylthiopiperidinderivate |
| DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
-
1995
- 1995-07-07 DE DE19524765A patent/DE19524765A1/de not_active Withdrawn
-
1996
- 1996-07-02 TW TW085108000A patent/TW332206B/zh active
- 1996-07-04 KR KR1019980700092A patent/KR19990028792A/ko not_active Application Discontinuation
- 1996-07-04 BR BR9609327A patent/BR9609327A/pt not_active Application Discontinuation
- 1996-07-04 CA CA002225411A patent/CA2225411A1/en not_active Abandoned
- 1996-07-04 JP JP9505482A patent/JPH11508904A/ja active Pending
- 1996-07-04 AU AU66113/96A patent/AU709208B2/en not_active Ceased
- 1996-07-04 CN CN96196744A patent/CN1195348A/zh active Pending
- 1996-07-04 NZ NZ313599A patent/NZ313599A/en unknown
- 1996-07-04 HU HU9900348A patent/HUP9900348A3/hu unknown
- 1996-07-04 WO PCT/EP1996/002939 patent/WO1997003072A1/de not_active Application Discontinuation
- 1996-07-04 CZ CZ19974233A patent/CZ288619B6/cs not_active IP Right Cessation
- 1996-07-04 SK SK2-98A patent/SK298A3/sk unknown
- 1996-07-04 PL PL96324436A patent/PL324436A1/xx unknown
- 1996-07-04 EP EP96925657A patent/EP0839147A1/de not_active Withdrawn
- 1996-07-04 IL IL12281596A patent/IL122815A0/xx unknown
- 1996-07-05 ZA ZA9605712A patent/ZA965712B/xx unknown
-
1998
- 1998-01-06 NO NO19980059A patent/NO310194B1/no not_active IP Right Cessation
- 1998-12-31 US US09/224,799 patent/US5972947A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX9800157A (es) | 1998-03-29 |
| KR19990028792A (ko) | 1999-04-15 |
| CA2225411A1 (en) | 1997-01-30 |
| NZ313599A (en) | 1999-10-28 |
| TW332206B (en) | 1998-05-21 |
| HUP9900348A2 (hu) | 1999-05-28 |
| CZ423397A3 (cs) | 1998-03-18 |
| US5972947A (en) | 1999-10-26 |
| ZA965712B (en) | 1998-01-05 |
| EP0839147A1 (de) | 1998-05-06 |
| CN1195348A (zh) | 1998-10-07 |
| JPH11508904A (ja) | 1999-08-03 |
| HUP9900348A3 (en) | 2000-11-28 |
| IL122815A0 (en) | 1998-08-16 |
| NO980059D0 (no) | 1998-01-06 |
| PL324436A1 (en) | 1998-05-25 |
| WO1997003072A1 (de) | 1997-01-30 |
| DE19524765A1 (de) | 1997-01-09 |
| BR9609327A (pt) | 1999-05-25 |
| AU6611396A (en) | 1997-02-10 |
| NO980059L (no) | 1998-01-06 |
| CZ288619B6 (cs) | 2001-08-15 |
| NO310194B1 (no) | 2001-06-05 |
| AU709208B2 (en) | 1999-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK298A3 (en) | New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds | |
| JP6453231B2 (ja) | ウレア誘導体、またはその薬理学的に許容される塩 | |
| US20090197884A1 (en) | Compounds Useful as Antagonists of CCR2 | |
| EP2385040A1 (de) | Stickstoffhaltige heterocyclische Derivate und Arzneimittel, die diese als Wirkstoff enthalten | |
| MXPA01012450A (es) | Inhibidores de metaloproteasas. | |
| WO2001044200A2 (en) | Selective neurokinin antagonists | |
| KR19990064178A (ko) | 1-(1,2-이치환된 피페리디닐)-4-치환된 피페라진 유도체 | |
| WO2002004402A1 (fr) | Derives d'ester | |
| US20120035214A1 (en) | Renin inhibitors | |
| EP1646620B1 (de) | Substituierte piperidine als histamin-h3-rezeptorliganden | |
| US5158947A (en) | Condensed heterocyclic compounds and psychopharmaceutical composition containing same | |
| CA2688057A1 (en) | Novel case of renin inhibitors | |
| AU689587B2 (en) | Dihygropyridine derivatives as bradykinin antagonists | |
| AU722747B2 (en) | Novel oxazolidine derivatives, process for their production and medicaments containing them | |
| US20020147222A1 (en) | Dihydropyridine derivatives | |
| MXPA98000157A (en) | New derivatives of oxazolidinone, processes to prepare the same and medicines that contain these compues | |
| HU190793B (en) | Process for preparing n-/ /4-phenyl-1,2,3,6-tetrahydro-pyridin-1-yl/-lakylene/-aza-spiro-alkane-diones and pharmaceutical compositions containing thereof as active substances | |
| EP1773823A1 (de) | 4-arylmorpholin-3-onderivate, herstellung und therapeutische verwendung dafür | |
| MXPA98008002A (en) | New derivatives of oxazolidine, production processes and pharmaceutical agents containing these compues | |
| DE19654479A1 (de) | Neue Oxazolidinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE19612827A1 (de) | Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |